Hepatitis C
NEW THERAPIES FOR HEPATITIS C
... Of course, for the sake of effectiveness, safety, and tolerability, the current therapy is insufficient to confront the present hepatitis C epidemic. Therefore, from a therapy with poorly understood ...
7
Clinical and aspects of Hepatitis B virus and Hepatitis C virus in FortalezaCeará
... of hepatitis differs ac- cording to the ...of hepatitis B virus (HBV) ranges from ...viral hepatitis is second place among the causes of liver disease ...[4-6]. Hepatitis C virus (HCV) ...
8
PATIENTS WITH CHRONIC HEPATITIS C AND NORMAL TRANSAMINASES
... TRUGENE HCV 5’NC genotyping kit: a 244-bp fragment from the 5’NC of the HCV genome was amplified by RT-PCR using the COBAS AMPLICOR Hepatitis C test (Roche Molecular Systems, Inc., Branchburg, N.J.). The ...
5
Therapy of chronic hepatitis C: Virologic response monitoring
... Terapija hroni čnog hepatitisa C (CHC) danas se izvodi kombinovanom terapijom: pegilovanim interferonom alfa2 (PEG-IFN) i ribavirinom. Dužina terapije i doza zavise od genotipa hepatitis C virusa. ...
5
A new evolutionary model for hepatitis C virus chronic infection.
... Hepatitis C virus (HCV) infects an estimated 3% of humanity [1] and is a leading global cause of liver disease and liver cancer [2]. Intervention is currently limited by the lack of a vaccine and of ...
4
Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients
... The mechanisms related to the spontaneous clearance of hepatitis C virus (HCV) have been primarily studied in regions where the infection is endemic. Results of prior studies have been extrapolated to ...
5
Hepatitis C: A Critical Analysis of Therapeutic Response Predictors
... Hepatitis C Virus is an RNA virus which may have certain degrees of transcription modifications in its genome, generating variants, defined as quasi-species. These are frequently developed under immune ...
8
DIAGNOSIS OF HEPATITIS C VIRUS IN BRAZILIAN BLOOD DONORS USING A REVERSE TRANSCRIPTASE NESTED POLYMERASE CHAIN REACTION: COMPARISON WITH ENZYME IMMUNOASSAY AND RECOMBINANT PROTEIN IMMUNOBLOT ASSAY
... Blood donors: Hepatitis C-infected blood donors in this study were identified during routine screening for HCV antibodies after blood donation. In our blood bank, annually around 30,000 units of blood are ...
5
Pathogenesis of Hepatitis C – HCV Consensus 2007
... Some MHC class II alleles, such as DR5, have been associated with a lower incidence of cirrhosis in individuals chronically infected with HCV [94]. Rehermann et al. [95] identified CTLs restricted by histocompatibility ...
6
Epidemiological profile of hepatitis c patients: a descriptive study on a regional reference unit
... with Hepatitis C in order that the results may help control this endemic disease, intensifying the prevention and detection of population vulnerable to acquiring the hepatitis C virus, as well ...
13
Hepatitis C Treatment Before and After Liver Transplant
... The use of older liver donors is a factor that negatively affects the fibrosis progression rate. Recent studies show a tendency toward a ten-year increase in the age of donors in the last decade. This measure, although ...
5
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
... Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year ...of hepatitis C virus ...
12
Molecular biology and clinical implication of hepatitis C virus
... recurrent hepatitis C ...recurrent hepatitis C led to severe disease, the number of HVR1 non-synonymous substitutions was greater than the number of synonymous sub- ...
5
Treatment for Chronic Hepatitis C: Drugs and Treatment Response Patterns
... The use of IFN-α was approved for hepatitis C treatment in 1991. At that time, the response to this immunotherapy was very low (< 20%). However, when the combination of ribavirin and IFN-α began to be ...
5
Noninvasive Means of Diagnosing Liver Fibrosis in Hepatitis C
... chronic hepatitis C showed that fragments of technically inadequate hepatic tissue frequently lead to the underestimation of the stage of liver fibrosis ...
5
Therapie der chronischen Hepatitis C Genotyp 1 Update 2015
... Patienten mit Relapse nach DAA-Therapie Der Großteil aller Patienten mit chronischer Hepatitis C Ge- notyp 1 kann mit den neuen DAA-Regimen virologisch ge- heilt werden. Bei einem geringen Anteil kommt es ...
11
Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study.
... for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum were ...blotting. Hepatitis B and human immunodefi- ciency virus infections were more frequent in ...
11
Hepatitis C and associated risks in prisons: an integrative review Hepatite C e riscos associados em presídios: uma revisão integrativa
... The prison population is at high risk of contracting infections that are related to conditions of confinement, including viral hepatitis. The impact of HCV infection is not limited only to prison populations, ...
7
SEXUAL TRANSMISSION OF HEPATITIS C VIRUS
... of hepatitis C virus (HCV) in Brazil, with special emphasis on sexual transmission, we determined the presence of HCV infection in regular partners and in non-sexual home communicants of blood donors seen ...
5
REVIEW SEXUAL TRANSMISSION OF HEPATITIS C
... hepatitis C, choosing 24 in whom both partners presented viremia, allowing a phylogenic analysis of the genomic chains of HCV between couples. The findings of this study revealed a similarity of 98.3% ...
7